what is folfirinox chemotherapy?

Q: what is folfirinox chemotherapy?

In short FOLFIRINOX is a combination chemotherapy that uses four medicines: oxaliplatin, irinotecan, fluorouracil (5-FU), and leucovorin [3]. It is used to treat pancreatic cancer that has spread or been removed by surgery [1]. Research shows it can help patients live longer than older treatments like gemcitabine alone [3][4]. The details FOLFIRINOX includes four drugs: oxaliplatin, irinotecan, fluorouracil (5-FU), and leucovorin [3]. For advanced or metastatic cancer (cancer that has spread), FOLFIRINOX is a standard treatment option for patients who are strong enough to handle it [1][3]. In studies of advanced cancer, patients taking FOLFIRINOX lived longer than those taking gemcitabine alone. The median survival was 11.1 months with FOLFIRINOX compared to 6.8 months with gemcitabine [3]. After surgery, a modified version of FOLFIRINOX is recommended for some patients to help prevent the cancer from coming back [1][4]. In studies after surgery, patients taking modified FOLFIRINOX had longer disease-free survival (21.6 months) and overall survival (54.4 months) compared to those taking gemcitabine [4]. It is also used for borderline resectable or locally advanced cancer, sometimes with other treatments like focused ultrasound [2]. What to know FOLFIRINOX causes more side effects than older treatments like gemcitabine [3][4]. Serious side effects can include low white blood cell counts (febrile neutropenia) and other toxicities [3][4]. It is generally only recommended for patients who are in good health and have a good performance status [3]. The information about adding focused ultrasound comes from an early exploratory study and needs more research to confirm its benefits [2].

Question

Accepted Answer

In short

FOLFIRINOX is a combination chemotherapy that uses four medicines: oxaliplatin, irinotecan, fluorouracil (5-FU), and leucovorin [3]. It is used to treat pancreatic cancer that has spread or been removed by surgery [1]. Research shows it can help patients live longer than older treatments like gemcitabine alone [3][4].

The details

FOLFIRINOX includes four drugs: oxaliplatin, irinotecan, fluorouracil (5-FU), and leucovorin [3].

For advanced or metastatic cancer (cancer that has spread), FOLFIRINOX is a standard treatment option for patients who are strong enough to handle it [1][3].

In studies of advanced cancer, patients taking FOLFIRINOX lived longer than those taking gemcitabine alone. The median survival was 11.1 months with FOLFIRINOX compared to 6.8 months with gemcitabine [3].

After surgery, a modified version of FOLFIRINOX is recommended for some patients to help prevent the cancer from coming back [1][4].

In studies after surgery, patients taking modified FOLFIRINOX had longer disease-free survival (21.6 months) and overall survival (54.4 months) compared to those taking gemcitabine [4].

It is also used for borderline resectable or locally advanced cancer, sometimes with other treatments like focused ultrasound [2].

What to know

FOLFIRINOX causes more side effects than older treatments like gemcitabine [3][4]. Serious side effects can include low white blood cell counts (febrile neutropenia) and other toxicities [3][4]. It is generally only recommended for patients who are in good health and have a good performance status [3]. The information about adding focused ultrasound comes from an early exploratory study and needs more research to confirm its benefits [2].